Literature DB >> 18054352

Oral eicosapentaenoic acid supplementation as possible therapy for endometriosis.

Sachiho Netsu1, Ryo Konno, Kohei Odagiri, Masaaki Soma, Hiroyuki Fujiwara, Mitsuaki Suzuki.   

Abstract

OBJECTIVE: To investigate the anti-inflammatory effect of n-3 eicosapentaenoic acid (EPA) compared with n-6 linoleic acid (LA) in an endometriosis rat model. We focused on the relationship between lipid metabolism and inflammatory reactions in endometriosis based on the hypothesis that a lipid intake imbalance is one of the factors responsible for the recent increase of endometriosis.
DESIGN: Prospective, randomized experimental study.
SETTING: Animal surgery laboratory in a university hospital. ANIMAL(S): Sprague-Dawley rats (female, 6 weeks old). INTERVENTION(S): Rats were fed a diet with EPA (n = 9) or with LA (n = 9) for 2 weeks. Two weeks after feeding, the uterus was autotransplanted to the peritoneum to construct an endometriosis model. Feeding was continued for a total of 6 weeks. Two and 4 weeks after autotransplantation, three rats of each group were killed and evaluated. MAIN OUTCOME MEASURE(S): Endometriotic lesions were morphologically evaluated and their fatty acid composition was examined. Gene expression in these tissues was evaluated by cDNA microarray analysis and quantative real-time reverse transcriptase-polymerase chain reaction (RT-PCR). RESULT(S): In the EPA group, the n-3:n-6 ratio in each tissue significantly increased and the thickening of the interstitium, an active site for inflammation in endometriosis, was significantly suppressed (0.30 +/- 0.09 mm [EPA group] vs. 0.77 +/- 0.23 mm [LA group]). The mRNA of metalloproteinases, interleukin-1beta, interleukin-1r, prostaglandin E synthase (Ptges), and nuclear factor (NF)-kappaB were reduced in the EPA group. CONCLUSION(S): EPA supplementation might be a valid strategy for the treatment of endometriosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054352     DOI: 10.1016/j.fertnstert.2007.08.014

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

1.  Serum Polyunsaturated Fatty Acids and Endometriosis.

Authors:  Margaret M Hopeman; Joan K Riley; Antonina I Frolova; Hui Jiang; Emily S Jungheim
Journal:  Reprod Sci       Date:  2014-12-23       Impact factor: 3.060

2.  Evaluation of the relationship between endometriosis and omega-3 and omega-6 polyunsaturated fatty acids.

Authors:  Korosh Khanaki; Mohammad Nouri; Ali M Ardekani; Alieh Ghassemzadeh; Vahideh Shahnazi; Mohammad R Sadeghi; Masoud Darabi; Amir Mehdizadeh; Homayon Dolatkhah; Abotaleb Saremi; Ali R Imani; Ali Rahimipour
Journal:  Iran Biomed J       Date:  2012

3.  High ω-3:ω-6 fatty acids ratio increases fatty acid binding protein 4 and extracellular secretory phospholipase A2IIa in human ectopic endometrial cells.

Authors:  Korosh Khanaki; Mohammad Reza Sadeghi; Mohammad Mehdi Akhondi; Masoud Darabi; Amir Mehdizadeh; Mahdi Shabani; Ali Rahimipour; Mohammad Nouri
Journal:  Iran J Reprod Med       Date:  2014-11

Review 4.  Self-management and psychological-sexological interventions in patients with endometriosis: strategies, outcomes, and integration into clinical care.

Authors:  Laura Buggio; Giussy Barbara; Federica Facchin; Maria Pina Frattaruolo; Giorgio Aimi; Nicola Berlanda
Journal:  Int J Womens Health       Date:  2017-05-02

Review 5.  Dietary supplements for treatment of endometriosis: A review.

Authors:  Pınar Yalçın Bahat; Işıl Ayhan; Eda Üreyen Özdemir; Ümit İnceboz; Engin Oral
Journal:  Acta Biomed       Date:  2022-03-14

6.  Omega-3 polyunsaturated Fatty acids suppress the cystic lesion formation of peritoneal endometriosis in transgenic mouse models.

Authors:  Kensuke Tomio; Kei Kawana; Ayumi Taguchi; Yosuke Isobe; Ryo Iwamoto; Aki Yamashita; Satoko Kojima; Mayuyo Mori; Takeshi Nagamatsu; Takahide Arimoto; Katsutoshi Oda; Yutaka Osuga; Yuji Taketani; Jing X Kang; Hiroyuki Arai; Makoto Arita; Shiro Kozuma; Tomoyuki Fujii
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

7.  Effect of polyunsaturated fatty acids on secretory phospholipase A2 type IIa in ectopic endometrial cells.

Authors:  Korosh Khanaki; Ali Motavalizadeh Ardekani; Alieh Ghassemzadeh; Vahideh Shahnazi; Mohammad Reza Sadeghi; Masoud Darabi; Amir Mehdizadeh; Abotaleb Saremi; Jafar Soleimani-Rad; Ali Reza Imani; Mohammad Nouri; Ali Rahimipour
Journal:  Iran J Reprod Med       Date:  2012-07

8.  A pilot randomised double blind controlled trial of the efficacy of purified fatty acids for the treatment of women with endometriosis-associated pain (PurFECT): study protocol.

Authors:  Ibtisam M Abokhrais; Philippa T K Saunders; Fiona C Denison; Ann Doust; Linda Williams; Andrew W Horne
Journal:  Pilot Feasibility Stud       Date:  2018-04-25

9.  A two-arm parallel double-blind randomised controlled pilot trial of the efficacy of Omega-3 polyunsaturated fatty acids for the treatment of women with endometriosis-associated pain (PurFECT1).

Authors:  Ibtisam M Abokhrais; Fiona C Denison; Lucy H R Whitaker; Philippa T K Saunders; Ann Doust; Linda J Williams; Andrew W Horne
Journal:  PLoS One       Date:  2020-01-17       Impact factor: 3.240

10.  Effectiveness of Dietary Interventions in the Treatment of Endometriosis: a Systematic Review.

Authors:  Konstantinos Nirgianakis; Katharina Egger; Dimitrios R Kalaitzopoulos; Susanne Lanz; Lia Bally; Michael D Mueller
Journal:  Reprod Sci       Date:  2021-03-24       Impact factor: 3.060

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.